Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery

INTRODUCTION: Eptifibatide is a platelet glycoprotein IIb/IIIa (GP IIb/IIIa) receptor antagonist that inhibits fibrinogen binding to the activated GP IIb/IIIa site and prevents platelet-platelet interaction and clot formation. GP IIb/IIIa inhibitors improve outcome in patients undergoing percutaneou...

Descripción completa

Detalles Bibliográficos
Autores principales: Boettcher, Brent T., Olund, Timothy J., Pagel, Paul S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099974/
https://www.ncbi.nlm.nih.gov/pubmed/27843778
http://dx.doi.org/10.5812/aapm.37575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099974/
https://www.ncbi.nlm.nih.gov/pubmed/27843778
http://dx.doi.org/10.5812/aapm.37575

Ejemplares similares